Chemomab Therapeutics Ltd. - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Chemomab Therapeutics Ltd. - ADR
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
/ 
Frequently asked questions
To buy Chemomab Therapeutics Ltd. - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Chemomab Therapeutics Ltd. - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Chemomab Therapeutics Ltd. - ADR is CMMB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Chemomab Therapeutics Ltd. - ADR has its primary listing on NASDAQ (Small cap). You can trade Chemomab Therapeutics Ltd. - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Chemomab Therapeutics Ltd. - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Chemomab Therapeutics Ltd. - ADR as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like Chemomab Therapeutics Ltd. - ADR or others.